MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Pulse Biosciences Market Cap 2011-2026 | PLSE
As of January 11, 2026 Pulse Biosciences has a market cap of $ 703 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Pulse Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 418 M | 95.7 M | 340 M | 794 M | 303 M | 220 M | 303 M | 68.6 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 794 M | 68.6 M | 318 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical instruments industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
639 M | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
17.3 B | $ 21.07 | 1.81 % | $ 10.7 B | USA |
 |
Becton, Dickinson and Company
BDX
|
56.2 B | $ 202.8 | -1.16 % | $ 58.3 B | USA |
 |
Luminex Corporation
LMNX
|
1.27 B | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
809 K | - | -9.52 % | $ 20.6 M | USA |
 |
ICU Medical
ICUI
|
3.65 B | $ 151.86 | 0.14 % | $ 3.7 B | USA |
 |
iRhythm Technologies
IRTC
|
3.49 B | $ 180.4 | -4.68 % | $ 5.63 B | USA |
 |
Repro Med Systems
KRMD
|
96.7 M | $ 5.67 | -2.41 % | $ 259 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
727 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.27 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
152 M | - | - | $ 282 M | USA |
 |
Masimo Corporation
MASI
|
8.96 B | $ 140.04 | 1.54 % | $ 7.46 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
6.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Merit Medical Systems
MMSI
|
5.94 B | $ 86.37 | -7.31 % | $ 5.03 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
9.68 M | $ 8.03 | -1.95 % | $ 162 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
15.6 B | - | -0.02 % | $ 16.3 B | USA |
 |
Alcon
ALC
|
42.6 B | $ 80.27 | -0.43 % | $ 40.4 B |  Schweiz |
 |
Predictive Oncology
POAI
|
8.29 M | $ 6.83 | 1.08 % | $ 37.2 M | USA |
 |
AtriCure
ATRC
|
1.91 B | $ 41.66 | -1.76 % | $ 1.96 B | USA |
 |
electroCore
ECOR
|
29.4 K | $ 5.62 | 11.73 % | $ 31 K | USA |
 |
Haemonetics Corporation
HAE
|
3.06 B | $ 82.2 | -2.19 % | $ 4.14 B | USA |
 |
AngioDynamics
ANGO
|
355 M | $ 9.97 | -0.8 % | $ 407 M | USA |
 |
Harvard Bioscience
HBIO
|
188 M | $ 0.64 | -1.79 % | $ 27.1 M | USA |
 |
The Cooper Companies
COO
|
16.3 B | $ 83.71 | 0.69 % | $ 16.7 B | USA |
 |
LeMaitre Vascular
LMAT
|
2.07 B | $ 84.83 | -0.25 % | $ 1.9 B | USA |
 |
Glaukos Corporation
GKOS
|
4.3 B | $ 113.09 | -0.93 % | $ 5.48 B | USA |
 |
InfuSystem Holdings
INFU
|
146 M | $ 8.61 | -4.01 % | $ 178 M | USA |
 |
Isoray
ISR
|
24.5 M | - | 0.03 % | $ 108 M | USA |
 |
Nephros
NEPH
|
22.5 M | $ 4.89 | -2.5 % | $ 50.8 M | USA |
 |
Utah Medical Products
UTMD
|
247 M | $ 59.83 | 1.87 % | $ 217 M | USA |
 |
Intuitive Surgical
ISRG
|
203 B | $ 587.18 | 0.36 % | $ 209 B | USA |
 |
Microbot Medical
MBOT
|
11.7 M | $ 2.08 | -5.02 % | $ 21.2 M |  Israel |
 |
Milestone Scientific
MLSS
|
69.4 M | $ 0.3 | 1.23 % | $ 23.9 M | USA |
 |
NeuroMetrix
NURO
|
8.71 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
3.68 B | $ 23.57 | -0.23 % | $ 4.06 B | USA |
 |
OraSure Technologies
OSUR
|
259 M | $ 2.63 | -1.13 % | $ 196 M | USA |
 |
Pro-Dex
PDEX
|
150 M | $ 41.51 | 0.51 % | $ 136 M | USA |
 |
Repligen Corporation
RGEN
|
10.8 M | $ 166.85 | 0.26 % | $ 9.3 M | USA |
 |
ResMed
RMD
|
35.1 B | $ 252.15 | 0.49 % | $ 36.8 B | USA |
 |
BioLife Solutions
BLFS
|
1.14 B | $ 24.8 | -0.6 % | $ 1.14 B | USA |
 |
STERIS plc
STE
|
24.2 B | $ 258.0 | -1.03 % | $ 25.4 B | USA |
 |
Stereotaxis
STXS
|
215 M | $ 2.53 | -2.13 % | $ 204 M | USA |
 |
Retractable Technologies
RVP
|
21 M | $ 0.76 | -2.53 % | $ 22.8 M | USA |
 |
STAAR Surgical Company
STAA
|
832 M | $ 22.06 | -1.96 % | $ 1.08 B | USA |
 |
Teleflex Incorporated
TFX
|
6.21 B | $ 112.75 | 2.49 % | $ 5.28 B | USA |
 |
West Pharmaceutical Services
WST
|
15.4 B | $ 275.51 | 0.1 % | $ 20.1 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
3.5 B | $ 12.76 | 2.2 % | $ 2.59 B | USA |